Screening has a central role in colorectal cancer (CRC) control. Different screening tests are
effective in reducing CRC-specific mortality. Influence on cancer incidence depends on test …

Background Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality. A
well-defined precursor lesion (adenoma) and a long preclinical course make CRC a …

Background & Aims: Despite poor performance, guaiac-based fecal occult blood tests (G-
FOBT) are most frequently implemented for colorectal cancer screening. Immunochemical …

OBJECTIVES: Although some studies have shown that the quantitative, immunochemical
fecal occult blood test (FOBT)(qFIT) has better performance characteristics than the standard …

Immunochemical faecal occult blood testing (FIT) provides quantitative test results, which
allows optimisation of the cut-off value for follow-up colonoscopy. We conducted a …

Background: Guaiac-based fecal occult blood tests (FOBTs) for colorectal cancer screening
are not specific for human hemoglobin and have low sensitivity. Automated-development …

Background: The guaiac faecal occult blood test (G-FOBT) is recommended as a screening
test for colorectal cancer but its low sensitivity has prevented its use throughout the world …

OBJECTIVES Guaiac fecal occult blood colorectal cancer (CRC) screening tests (FOBT) are
faulted for low sensitivity and nonspecificity for human hemoglobin (Hb). Automated …

Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer
screening and diagnosis have been developed by experts in a project coordinated by the …

BACKGROUND & AIMS: Two European randomized trials (N= 30,000) compared guaiac
fecal occult blood testing with quantitative fecal immunochemical testing (FIT) and showed …